Publication: 3716

Publication: 3716

ALLIANCE A082002 -A RANDOMIZED PHASE II/III TRIAL OF MODERN IMMUNOTHERAPY-BASED SYSTEMIC THERAPY WITH OR WITHOUT SBRT FOR PD-L1-NEGATIVE, ADVANCED NON-SMALL CELL LUNG CANCER

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Clin Lung Cancer vol 23 (5) e317-e320

Year:: 2022
Type:: Manuscript
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA232760, UG1CA233180, UG1CA233191, UG1CA233253, UG1CA233277, U10CA180820 (ECOG-ACRIN), U10CA180888 (SWOG), U10CA180868 (NRG)

Corr. Author:
Authors:: STEVEN E. SCHILD XIAOFEI WANG CHRISTINE M. BESTVINA TERENCE WILLIAMS GREG MASTERS ANURAG SINGH THOMAS E. STINCHCOMBE JOSEPH K. SALAMA STEVEN WOLF TYLER ZEMLA NARJUST DUMA STEPHEN G. CHUN ARYA AMINI DAVID KOZONO COLLEEN WATT

Networks:: CA043, KANSAS, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, LAPS-TX035

Study: Alliance-A082002
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords:: Lung Cancer, stereotactic body radiation therapy, immunotherapy, chemotherapy